The effect of bronchodilator aerosols on the peak expiratory flow rate in asthmatic patients.
D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D001285:Atropine / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use*; D009921:Metaproterenol / Q000627:therapeutic use; D010656:Phenylephrine / Q000627:therapeutic use*; D010919:Placebos; D012129:Respiratory Function Tests; D013566:Sympathomimetics / Q000627:therapeutic use*
D000336:Aerosols; D001993:Bronchodilator Agents; D010919:Placebos; D013566:Sympathomimetics; D010656:Phenylephrine; D009921:Metaproterenol; D001285:Atropine; D007545:Isoproterenol